Tumors or cancer of the INTESTINES.
The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
Postmortem examination of the body.
Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness.
Physicians appointed to investigate all cases of sudden or violent death.
The application of pathology to questions of law.
Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.

Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine? (1/1156)

Early post-operative local or systemic administration of 5-fluorouracil (5-FU) is under investigation as a means to improve outcome after resection of intestinal malignancies. It is therefore quite important to delineate accurately its potentially negative effects on anastomotic repair. Five groups (n = 24) of rats underwent resection and anastomosis of both ileum and colon: a control group and four experimental groups receiving daily 5-FU, starting immediately after operation or after 1, 2 or 3 days. Within each group, the drug (or saline) was delivered either intraperitoneally (n = 12) or intravenously (n = 12). Animals were killed 7 days after operation and healing was assessed by measurement of anastomotic bursting pressure, breaking strength and hydroxyproline content. In all cases, 5-FU treatment from the day of operation or from day 1 significantly (P<0.025) and severely suppressed wound strength; concomitantly, the anastomotic hydroxyproline content was reduced. Depending on the location of the anastomosis and the route of 5-FU administration, even a period of 3 days between operation and first dosage seemed insufficient to prevent weakening of the anastomosis. The effects of intravenous administration, though qualitatively similar, were quantitatively less dramatic than those observed after intraperitoneal delivery. Post-operative treatment with 5-FU, if started within the first 3 days after operation, is detrimental to anastomotic strength and may compromise anastomotic integrity.  (+info)

Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. (2/1156)

Overexpression of cell surface glycoproteins of the CD44 family is an early event in the colorectal adenoma-carcinoma sequence. This suggests a link with disruption of APC tumor suppressor protein-mediated regulation of beta-catenin/Tcf-4 signaling, which is crucial in initiating tumorigenesis. To explore this hypothesis, we analyzed CD44 expression in the intestinal mucosa of mice and humans with genetic defects in either APC or Tcf-4, leading to constitutive activation or blockade of the beta-catenin/Tcf-4 pathway, respectively. We show that CD44 expression in the non-neoplastic intestinal mucosa of Apc mutant mice is confined to the crypt epithelium but that CD44 is strongly overexpressed in adenomas as well as in invasive carcinomas. This overexpression includes the standard part of the CD44 (CD44s) as well as variant exons (CD44v). Interestingly, deregulated CD44 expression is already present in aberrant crypt foci with dysplasia (ACFs), the earliest detectable lesions of colorectal neoplasia. Like ACFs of Apc-mutant mice, ACFs of familial adenomatous polyposis (FAP) patients also overexpress CD44. In sharp contrast, Tcf-4 mutant mice show a complete absence of CD44 in the epithelium of the small intestine. This loss of CD44 concurs with loss of stem cell characteristics, shared with adenoma cells. Our results indicate that CD44 expression is part of a genetic program controlled by the beta-catenin/Tcf-4 signaling pathway and suggest a role for CD44 in the generation and turnover of epithelial cells.  (+info)

Library of sequence-specific radioimmunoassays for human chromogranin A. (3/1156)

BACKGROUND: Human chromogranin A (CgA) is an acidic protein widely expressed in neuroendocrine tissue and tumors. The extensive tissue- and tumor-specific cleavages of CgA at basic cleavage sites produce multiple peptides. METHODS: We have developed a library of RIAs specific for different epitopes, including the NH2 and COOH termini and three sequences adjacent to dibasic sites in the remaining part of CgA. RESULTS: The antisera raised against CgA(210-222) and CgA(340-348) required a free NH2 terminus for binding. All antisera displayed high titers, high indexes of heterogeneity ( approximately 1.0), and high binding affinities (Keff0 approximately 0.1 x 10(12) to 1.0 x 10(12) L/mol), implying that the RIAs were monospecific and sensitive. The concentration of CgA in different tissues varied with the assay used. Hence, in a carcinoid tumor the concentration varied from 0.5 to 34.0 nmol/g tissue depending on the specificity of the CgA assay. The lowest concentration in all tumors was measured with the assay specific for the NH2 terminus of CgA. This is consistent with the relatively low concentrations measured in plasma from carcinoid tumor patients by the N-terminal assay, whereas the assays using antisera raised against CgA(210-222) and CgA(340-348) measured increased concentrations. CONCLUSION: Only some CgA assays appear useful for diagnosis of neuroendocrine tumors, but the entire library is valuable for studies of the expression and processing of human CgA.  (+info)

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. (4/1156)

Expression of cyclooxygenase 2 (COX-2) is believed to play an important role in adenoma formation in murine polyposis models, and inhibition of COX-2 activity may, at least, partly explain the chemopreventative activity of non-steroidal anti-inflammatory drugs against colorectal cancer in humans. However, the mechanism by which COX-2 acts in intestinal tumorigenesis remains unresolved because of conflicting data on the cellular localization of COX-2 in intestinal mucosa. Using immunohistochemistry with specific COX-2 antiserum, we have shown that COX-2 protein is localized to interstitial cells at the base of and within adenomas of the small and large intestine of multiple intestinal neoplasia (Min) mice. No COX-2 staining was observed in dysplastic epithelial cells within adenomas or in histologically normal epithelium. Moreover, COX-2 staining was observed in lamina propria cells of histologically normal intestine of Min mice. No staining was demonstrated in wild-type littermates. The rat monoclonal antibody F4/80 was used to show that COX-2-positive cells represented a subset of the macrophage population present in the intestine of Min mice. Localization of COX-2 to macrophages implies a paracrine effect of COX-2 function on epithelial cells in adenomas and also on histologically normal epithelium. Up-regulation of COX-2 expression in lamina propria macrophages may precede loss of the second functional Apc allele in epithelial cells before adenoma formation in the Min mouse model of intestinal tumorigenesis.  (+info)

Promotion of intestinal carcinogenesis by dietary methionine. (5/1156)

The metabolism of the polyamines spermidine and spermine is known to be enhanced in rapidly proliferating cells. Methionine is a precursor of the aminopropyl moieties of these amines. Therefore, it was of interest to study the effects of a methionine supplemented diet on polyamine metabolism and preneoplastic changes occurring in the intestinal tract of rats treated with the chemical carcinogen azoxymethane (AOM). Adult Wistar rats received 15 mg AOM/kg body wt (i.p.) once each week for 2 weeks. Thereafter, the rats were randomly divided into two groups and received controlled isoenergetic diets containing the same amount of folate, choline and vitamin B12 during 12 weeks: one group was kept on a standard diet; the other was fed the same diet, except that 1% L-methionine was added at the expense of carbohydrates. After 12 weeks, the administration of the methionine-supplemented diet stimulated the turnover rate of ileal epithelial cells, indicating enhanced crypt cell proliferation. Furthermore, in this group, a 2-fold increase in the number of aberrant hyperproliferative crypts and the appearance of tumors was observed in the colon. These effects were accompanied by the increased formation of spermidine and spermine due to the enhancement of S-adenosylmethionine decarboxylase activity and by the upregulation of Cdx-1, a homeobox gene with oncogenic potentials. The experimental data do not support the view of a chemopreventive effect of dietary methionine supplementation on intestinal carcinogenesis in rats, even at an early phase of preneoplastic development, but rather suggest that methionine promotes intestinal carcinogenesis.  (+info)

Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse. (6/1156)

Recent experimental and epidemiological evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in the prevention of colorectal cancer. However, the toxicity associated with the long-term use of most classical NSAIDs has limited their usefulness for the purpose of cancer chemoprevention. Inflammatory bowel disease (IBD) patients, in particular, are sensitive to the adverse side effects of NSAIDs, and these patients also have an increased risk for the development of intestinal cancer. 5-Aminosalicylic acid (5-ASA) is an anti-inflammatory drug commonly used in the treatment of IBD and may provide protection against the development of colorectal cancer in these patients. To directly evaluate the ability of 5-ASA to suppress intestinal tumors, we studied several formulations of 5-ASA (free acid, sulfasalazine, and Pentasa) at multiple oral dosage levels [500, 2400, 4800, and 9600 parts/million (ppm)] in the adenomatous polyposis coli (Apc) mouse model of multiple intestinal neoplasia (Min). Although the ApcMin mouse is not a model of colitis-associated neoplasia, it is, nonetheless, a useful model for assessing the ability of anti-inflammatory agents to prevent tumor formation in a genetically preinitiated population of cells. We used a study design in which drug was provided ad libitum through the diet beginning at the time of weaning (28 days of age) until 100 days of age. We included 200 ppm of piroxicam and 160 ppm of sulindac as positive controls, and the negative control was AIN-93G diet alone. Treatment with either piroxicam or sulindac produced statistically significant reductions in intestinal tumor multiplicity (95% and 83% reductions in tumor number, respectively; P < 0.001 versus controls). By contrast, none of the 5-ASA drug formulations or dosage levels produced consistent dose-progressive changes in polyp number, distribution, or size, despite high luminal and serum concentrations of 5-ASA and its primary metabolite N-acetyl-5-ASA. Thus, 5-ASA does not seem to possess direct chemosuppressive activity against the development of nascent intestinal adenomas in the ApcMin mouse. However, because intestinal tumor development in the ApcMin mouse is driven by a germline mutation in the Apc gene rather than by chronic inflammation, we caution that these findings do not definitively exclude the possibility that 5-ASA may exert a chemopreventive effect in human IBD patients.  (+info)

Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice. (7/1156)

Non-steroidal anti-inflammatory drugs (NSAIDs) can cause regression of early intestinal tumors and although this is believed to involve cyclooxygenase-2 and apoptosis, the molecular mechanisms remain unclear. Cytoplasmic and nuclear beta-catenin are overexpressed in many of these lesions and Bcl-2, which inhibits apoptosis, may also be elevated during the course of intestinal tumorigenesis. We recently showed that sulindac causes regression of 70-80% of small intestinal tumors in Min/+ mice within 4 days, but does not have the same impact on colonic lesions; after 20 days of treatment the tumor load stabilizes at 10-20% of that in untreated animals. The aim of this study was to determine if NSAID-induced regression of intestinal adenomas might be associated with changes in beta-catenin or Bcl-2 expression. Intestinal tumors from Min/+ mice were harvested after treatment with sulindac for 2, 4 or 20 days and evaluated for expression of beta-catenin and Bcl-2 using immunohistochemistry. There was a > or = 50% decrease in beta-catenin (P = 0.001) and diminishing Bcl-2 (P = 0.019) in small intestinal tumors harvested between 2 and 4 days of treatment when compared with untreated controls. In contrast, small intestinal tumors from animals treated for 20 days were not significantly different from untreated controls. Colonic tumors expressed higher levels of Bcl-2 than those from the small intestine and did not show any significant changes in either Bcl-2 or beta-catenin expression after treatment. Results suggest that modulation of aberrant beta-catenin expression occurs during NSAID-induced regression of intestinal adenomas and that Bcl-2 may confer resistance to these effects.  (+info)

Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months. (8/1156)

The Apc1638N mouse model, which carries a targeted mutant allele within the adenomatous polyposis (Apc) gene and develops intestinal tumours spontaneously, predominantly in the small bowel, was used to investigate the effects of two potential chemopreventive agents, aspirin and alpha-amylase resistant starch (RS). Heterozygous Apc+/Apc1638N mice were fed semi-purified diets rich in animal fat, animal proteins and sucrose and low in dietary fibre (Western style diets) from approximately 6 weeks up to 6 months of age. Two of the diets contained aspirin (300 mg/kg diet) and two RS (1:1 mixture of raw potato starch: Hylon VII at 200 g/kg diet) in a 2 x 2 factorial design. A fifth treatment group were fed a conventional rodent chow diet. The mice fed the Western style diets became almost three times as fat as the chow-fed mice but this did not affect tumour yield. Treatment with RS resulted in significantly more intestinal tumours whereas aspirin alone had no effect. However, there was a significant aspirin x RS interaction, which suggests that aspirin could prevent the small intestine tumour-enhancing effects of RS in this Apc-driven tumorigenesis model. The possibility that large amounts of purified forms of resistant starch may have adverse effects within the small bowel is a novel observation that requires further investigation since greater intakes of starchy foods (and of RS) are being encouraged as a public health measure in compensation for reduced dietary fat intake. However, it remains possible that any increased risk is restricted to carriers of germline mutations in APC.  (+info)

Intestinal neoplasms refer to abnormal growths in the tissues of the intestines, which can be benign or malignant. These growths are called neoplasms and they result from uncontrolled cell division. In the case of intestinal neoplasms, these growths occur in the small intestine, large intestine (colon), rectum, or appendix.

Benign intestinal neoplasms are not cancerous and often do not invade surrounding tissues or spread to other parts of the body. However, they can still cause problems if they grow large enough to obstruct the intestines or cause bleeding. Common types of benign intestinal neoplasms include polyps, leiomyomas, and lipomas.

Malignant intestinal neoplasms, on the other hand, are cancerous and can invade surrounding tissues and spread to other parts of the body. The most common type of malignant intestinal neoplasm is adenocarcinoma, which arises from the glandular cells lining the inside of the intestines. Other types of malignant intestinal neoplasms include lymphomas, sarcomas, and carcinoid tumors.

Symptoms of intestinal neoplasms can vary depending on their size, location, and type. Common symptoms include abdominal pain, bloating, changes in bowel habits, rectal bleeding, weight loss, and fatigue. If you experience any of these symptoms, it is important to seek medical attention promptly.

Sudden death is a term used to describe a situation where a person dies abruptly and unexpectedly, often within minutes to hours of the onset of symptoms. It is typically caused by cardiac or respiratory arrest, which can be brought on by various medical conditions such as heart disease, stroke, severe infections, drug overdose, or trauma. In some cases, the exact cause of sudden death may remain unknown even after a thorough post-mortem examination.

It is important to note that sudden death should not be confused with "sudden cardiac death," which specifically refers to deaths caused by the abrupt loss of heart function (cardiac arrest). Sudden cardiac death is often related to underlying heart conditions such as coronary artery disease, cardiomyopathy, or electrical abnormalities in the heart.

An autopsy, also known as a post-mortem examination or obduction, is a medical procedure in which a qualified professional (usually a pathologist) examines a deceased person's body to determine the cause and manner of death. This process may involve various investigative techniques, such as incisions to study internal organs, tissue sampling, microscopic examination, toxicology testing, and other laboratory analyses. The primary purpose of an autopsy is to gather objective evidence about the medical conditions and factors contributing to the individual's demise, which can be essential for legal, insurance, or public health purposes. Additionally, autopsies can provide valuable insights into disease processes and aid in advancing medical knowledge.

Bereavement is the state of loss or grief experienced when a person experiences the death of a loved one, friend, or family member. It is a normal response to the death of someone close and can involve a range of emotions such as sadness, anger, guilt, and anxiety. The grieving process can be different for everyone and can take time to work through. Professional support may be sought to help cope with the loss.

A coroner and medical examiner are officials in the legal system who are responsible for investigating and determining the cause of death in certain cases. While their roles can overlap, there are some differences between them.

A coroner is a public official who is typically appointed or elected to serve in a particular jurisdiction, such as a county or district. The coroner's primary responsibility is to investigate any sudden, unexpected, or suspicious deaths that occur within their jurisdiction. This may include deaths that occur due to violence, accidents, suicide, or unknown causes.

In order to determine the cause of death, the coroner may conduct an autopsy, order toxicology tests, and review medical records and other evidence. The coroner may also hold an inquest, which is a formal hearing in which witnesses are called to testify about the circumstances surrounding the death. Based on the evidence gathered during the investigation, the coroner will make a determination as to the cause and manner of death.

A medical examiner, on the other hand, is a physician who has completed specialized training in forensic pathology. Medical examiners are typically appointed or hired by a government agency, such as a state or county, to perform autopsies and investigate deaths.

Medical examiners are responsible for determining the cause of death in cases where there is a suspicion of foul play, as well as in other circumstances where the cause of death may not be immediately apparent. They may also testify in court as expert witnesses based on their findings.

In some jurisdictions, the roles of coroner and medical examiner are combined, with the official serving as both a public administrator and a trained physician. In other cases, the two roles are separate, with the coroner responsible for administrative functions and the medical examiner responsible for determining the cause of death.

Forensic pathology is a subspecialty of pathology that focuses on determining the cause and manner of death by examining a corpse. It involves applying scientific knowledge and techniques to investigate criminal or suspicious deaths, often in conjunction with law enforcement agencies. A forensic pathologist performs autopsies (postmortem examinations) to evaluate internal and external injuries, diseases, and other conditions that may have contributed to the individual's death. They also collect evidence such as tissue samples, which can be used for toxicological, microbiological, or histological analysis. The information gathered by forensic pathologists is crucial in helping to establish the facts surrounding a person's death and assisting legal proceedings.

The "cause of death" is a medical determination of the disease, injury, or event that directly results in a person's death. This information is typically documented on a death certificate and may be used for public health surveillance, research, and legal purposes. The cause of death is usually determined by a physician based on their clinical judgment and any available medical evidence, such as laboratory test results, autopsy findings, or eyewitness accounts. In some cases, the cause of death may be uncertain or unknown, and the death may be classified as "natural," "accidental," "homicide," or "suicide" based on the available information.

"Terminology as a topic" in the context of medical education and practice refers to the study and use of specialized language and terms within the field of medicine. This includes understanding the meaning, origins, and appropriate usage of medical terminology in order to effectively communicate among healthcare professionals and with patients. It may also involve studying the evolution and cultural significance of medical terminology. The importance of "terminology as a topic" lies in promoting clear and accurate communication, which is essential for providing safe and effective patient care.

... can refer to: Small intestine cancer Colorectal cancer This disambiguation page lists articles associated ... with the title Intestinal neoplasms. If an internal link led you here, you may wish to change the link to point directly to the ...
ISBN 92-832-2416-7. Gill SS, Heuman DM, Mihas AA (October 2001). "Small intestinal neoplasms". Journal of Clinical ... Benign neoplasms are typically, but not always, composed of cells which bear a strong resemblance to a normal cell type in ... Articles with short description, Short description is different from Wikidata, Medical terminology, Benign neoplasms). ... Bannayan-Riley-Ruvalcaba syndrome is a congenital disorder characterized by hamartomatous intestinal polyposis, macrocephaly, ...
... malignant neoplasms intestinal obstruction; decubitus ulcers; dental extraction; sickle cell disease; diabetes mellitus; ...
... intestinal neoplasms MeSH C04.588.274.476.411.184 - cecal neoplasms MeSH C04.588.274.476.411.184.290 - appendiceal neoplasms ... skull base neoplasms MeSH C04.588.149.828 - spinal neoplasms MeSH C04.588.180.260 - breast neoplasms, male MeSH C04.588.180.390 ... bile duct neoplasms MeSH C04.588.274.120.250.250 - common bile duct neoplasms MeSH C04.588.274.120.401 - gallbladder neoplasms ... femoral neoplasms MeSH C04.588.149.721 - skull neoplasms MeSH C04.588.149.721.450 - jaw neoplasms MeSH C04.588.149.721.450.583 ...
... intestinal neoplasms MeSH C06.301.371.411.184 - cecal neoplasms MeSH C06.301.371.411.184.290 - appendiceal neoplasms MeSH ... intestinal neoplasms MeSH C06.405.249.411.184 - cecal neoplasms MeSH C06.405.249.411.184.290 - appendiceal neoplasms MeSH ... intestinal neoplasms MeSH C06.405.469.491.184 - cecal neoplasms MeSH C06.405.469.491.184.290 - appendiceal neoplasms MeSH ... duodenal neoplasms MeSH C06.301.371.411.501 - ileal neoplasms MeSH C06.301.371.411.512 - immunoproliferative small intestinal ...
... violet is absorbed into intestinal and neoplastic cells and is used to identify Barrett's esophagus and colonic neoplasms.[ ... Barrett's esophagus involves change in the mucosa of the esophagus into a tissue that includes glands (intestinal metaplasia), ...
By light microscopy and immunohistochemistry: Gastric, intestinal, pancreaticbiliary, and oncocytic. The treatment of choice ... Pancreatic serous cystadenoma Solid pseudopapillary neoplasm "Intraductal Papillary Mucinous Neoplasms of the Pancreas". Johns ... Intraductal papillary mucinous neoplasm (IPMN) is a type of tumor that can occur within the cells of the pancreatic duct. IPMN ... Campbell, NM; Katz, SS; Escalon, JG; Do, RK (March 2015). "Imaging patterns of intraductal papillary mucinous neoplasms of the ...
1996). "Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice". Cancer Res. 56 (16): 3842-9. PMID 8706033 ... 1999). "Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene". EMBO J. 18 (21): 5931-42. doi: ... 1998). "Enhanced intestinal adenomatous polyp formation in Pms2-/-;Min mice". Cancer Res. 58 (6): 1087-9. PMID 9515784. Engle ... This mouse model is called Min (multiple intestinal neoplasia) mouse. It was found to carry a truncation mutation at codon 850 ...
Matutes E (May 2018). "The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms". International Journal of ... Tian S, Xiao SY, Chen Q, Liu H, Ping J (2019). "Monomorphic epitheliotropic intestinal T-cell lymphoma may mimic intestinal ... also termed a third type of intestinal T cell lymphoma that could not be classified as ATL or MEITL as intestinal T cell ... Tang XF, Yang L, Duan S, Guo H, Guo QN (December 2018). "Intestinal T-cell and NK/T-cell lymphomas: A clinicopathological study ...
Bowel obstruction: mechanical or functional obstruction of the bowel, most commonly due to adhesions, hernias or neoplasms. ... It is characterized by the signs and symptoms of intestinal obstruction without any lesion in the intestinal lumen. Clinical ... "Pediatric Intestinal Failure". Children's National. Retrieved 8 November 2021. "Intestinal Failure". Top Doctors United Kingdom ... A potential solution, albeit radical, is intestinal transplantation. This is only appropriate in the case of intestinal failure ...
... such as intestinal epithelium), basement membranes, and certain neoplasms. Osteonectin is expressed by a wide variety of cells ...
... such neoplasms may not require surgical excision.[citation needed] Small intestinal neuroendocrine tumors were first ... High levels of CDX2, a homeobox gene product essential for intestinal development and differentiation, are seen in intestinal ... G1 and G2 neuroendocrine neoplasms are called neuroendocrine tumors (NETs) - formerly called carcinoid tumours. G3 neoplasms ... Although there are many kinds of NETs, they are treated as a group of tissue because the cells of these neoplasms share common ...
... intestinal duplications, and pulmonary inclusions as seen with cystic fibrosis. It can be dangerous to biopsy a number of types ... ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of ... The word neoplasm is from Ancient Greek νέος- neo 'new' and πλάσμα plasma 'formation, creation'. A neoplasm can be benign, ... The process that occurs to form or produce a neoplasm is called neoplasia. The growth of a neoplasm is uncoordinated with that ...
... esophageal cancer gastric cancer small intestinal cancer colorectal cancer anal cancer In 2020 there were approximately 19.3 ... Digestive system neoplasms are tumors which affect the digestive system. There are many different and various pathologic ... classification for digestive system neoplasms. Considering the part of the digestive system that they origin, they are ...
In humans, trichophagia may lead to Rapunzel syndrome, an extremely rare but potentially fatal intestinal condition. Keratin ... Tumors that express keratin include carcinomas, thymomas, sarcomas and trophoblastic neoplasms. Furthermore, the precise ...
... neoplasms, and cysts, All stub articles, Epidermal nevi, neoplasm, cyst stubs). ... Multifocal occurrence is associated with Cowden syndrome, in which hamartomatous intestinal polyposis is seen in conjunction ... Trichilemmoma (also known as "tricholemmoma") is a benign cutaneous neoplasm that shows differentiation toward cells of the ... Cowden syndrome Trichilemmal carcinoma List of cutaneous conditions List of cutaneous neoplasms associated with systemic ...
"Intestinal obstruction and Ileus". MedlinePlus. Retrieved July 10, 2021. Zbar AP, Wexner SD (2010). Coloproctology. New York: ... Neoplasms / cancer Diverticulitis / Diverticulosis Hernias Inflammatory bowel disease Colonic volvulus (sigmoid, caecal, ... Bowel obstruction, also known as intestinal obstruction, is a mechanical or functional obstruction of the intestines which ... Intestinal atresia After abdominal surgery, the incidence of small bowel obstruction from any cause is 9%. In those where the ...
In addition, dogs with Lundehund Syndrome are predisposed to chronic atrophic gastritis and gastric neoplasms. A major issue ... Norwegian Lundehund are predisposed to develop intestinal lymphangiectasia, commonly known as Lundehund Syndrome, a protein- ...
It is about 2.5 m (8 ft) long, and contains the circular folds, and intestinal villi that increase its surface area. Products ... Viral infections Rotavirus Norovirus Astrovirus Adenovirus Calicivirus Neoplasms (cancers) Adenocarcinoma Carcinoid ... "Intestinal immune cells play an unexpected role in immune surveillance of the bloodstream". Massachusetts General Hospital. 13 ... First stage of the development of the intestinal canal and the peritoneum, seen from the side (diagrammatic). From colon 1 the ...
... is specifically expressed in human liver as well as in mouse bone marrow and intestinal tissues. Ni et al. showed that ... and GPR128 has been identified in the genome of patients with atypical myeloproliferative neoplasms. Notably, the fused gene ... "Deletion of Gpr128 results in weight loss and increased intestinal contraction frequency". World Journal of Gastroenterology. ... Gpr128 deletion in mice causes reduced body weight and induced intestinal contraction frequency. A 111-kb copy number gain with ...
An anatomic lead point (that is, a piece of intestinal tissue that protrudes into the bowel lumen) is present in approximately ... of bowel obstructions and is frequently associated with neoplasm, malignant or otherwise. Marsicovetere, P; Ivatury, SJ; White ... Cera, SM (2008). "Intestinal Intussusception". Clin Colon Rectal Surg. 21 (2): 106-13. doi:10.1055/s-2008-1075859. ISSN 1531- ... Risk factors in children include certain infections, diseases like cystic fibrosis, and intestinal polyps. Risk factors in ...
v t e (Articles with short description, Short description is different from Wikidata, Sarcoma, All stub articles, Neoplasm ... Takami Y, Masumoto H, Terasawa A, Kanai M, Sugiura H (2007). "Left atrial myxosarcoma with previously detected intestinal ...
An adrenal tumor or adrenal mass is any benign or malignant neoplasms of the adrenal gland, several of which are notable for ... and may produce severe watery diarrhea through production of vasoactive intestinal peptide. Treatment of neuroblastoma includes ... Pheochromocytoma is a neoplasm composed of cells similar to the chromaffin cells of the mature adrenal medulla. ... Saab ST, MacLennan GT (2015). "Adrenal Cortical Neoplasms: Perspectives in Pediatric Patients". In Santulli G (ed.). Adrenal ...
Sacchettini JC, Gordon JI, Banaszak LJ (July 1989). "Crystal structure of rat intestinal fatty-acid-binding protein. Refinement ... a marker for studying cellular differentiation in gut epithelial neoplasms". Gastroenterology. 99 (6): 1727-35. doi:10.1016/ ... "Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins". Annals of Surgery. 253 (2): 303-8 ... "The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and ...
It is shown that mice given 20 µg/kg body weight 4 times a week during a period of 28 weeks developed neoplasms of the liver. ... It is apparent that a significant amount of the oral dose passes the intestinal barrier. Microcystins do not appear to show ...
Virchows Arch 2018;473:265-73 Qubaiah, O.; Devesa, S. S.; Platz, C. E.; Huycke, M. M.; Dores, G. M. (2010). "Small Intestinal ... Malignant Neoplasms of the Small Intestine. eMedicine.com. URL: http://www.emedicine.com/MED/topic2651.htm. Accessed on: June 2 ... Cancer Res 2008;68:9274-9 Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in ... increases the risk of small intestinal adenocarcinomas, and this risk declines with increasing distance from the common bile ...
Gastrointestinal stromal tumors consist of a cluster of mesenchymal neoplasms that are formed from precursors to cells that ... though they can also be located in the small intestine or elsewhere in the intestinal tract. The cells of these tumors have a ...
2008). "l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms". Cancer Sci. 99 ... Bröer S (2008). "Amino acid transport across mammalian intestinal and renal epithelia". Physiol. Rev. 88 (1): 249-86. doi: ...
Abdominal neoplasms Aberrant subclavian artery Ablepharon macrostomia syndrome Abnormal systemic venous return Abruzzo-Erickson ... total intestinal Aggressive fibromatosis Aging Agnathia Agnathia holoprosencephaly situs inversus Agnosia, primary visual ... X-linked Adrenal incidentaloma Adrenal insufficiency Adrenal macropolyadenomatosis Adrenal medulla neoplasm Adrenocortical ... cutis congenita Aplasia cutis congenita dominant Aplasia cutis congenita epibulbar dermoids Aplasia cutis congenita intestinal ...
"Stool". Lewis SJ, Heaton KW (September 1997). "Stool form scale as a useful guide to intestinal transit time". Scandinavian ... ulcerative colitis and neoplasms (cancer). Also, feces may be analyzed for any fecal occult blood, which is indicative of a ... The remaining solids are composed of insoluble calcium and iron phosphate salts, intestinal secretions, small amounts of dried ... coli O157 if blood is visible in the stool sample Cryptosporidium Entamoeba histolytica Intestinal parasites and their ova ( ...
Intestinal neoplasms can refer to: Small intestine cancer Colorectal cancer This disambiguation page lists articles associated ... with the title Intestinal neoplasms. If an internal link led you here, you may wish to change the link to point directly to the ...
Neuroendocrine neoplasms are rare and their treatment is not standardized due to a lack of data. The present case highlights ... as these are possible in grade 1 and grade 2 neuroendocrine neoplasms including gastroenteropancreatic neuroendocrine neoplasms ...
Gastrointestinal reconstruction by intestinal auto-transplantation after radical resection of neoplasms involving superior ... When abdominal neoplasms originating from the pancreas or nearby organs locally involving the superior mesenteric artery (SMA ... Intestinal autotransplantation has recently emerged in clinical practice as a treatment option for selected patients with ... Gastrointestinal reconstruction by intestinal auto-transplantation after radical resectio [ ...
These processes can be divided into acute intestinal obstructions and chronic, partial intestinal obstructions. ... Intestinal neoplasm. * Foreign material from previous operations, such as surgical staples after laparoscopic appendectomy ( ... Meckels diverticulitis causing intestinal obstruction in a 3 month old infant. J Res Med Sci. 2013 Sep. 18(9):826. [QxMD ... Duodenal and intestinal atresia and stenosis. In: Holcomb GW III, Murphy JP, St Peter SD, eds. Holcomb and Ashcrafts Pediatric ...
The distribution of GEP NETs differs regionally as in North America small intestinal and rectal NETs are most prevalent, in ... Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? Curr Oncol Rep. 2021 Mar 14; ... The distribution of GEP NETs differs regionally as in North America small intestinal and rectal NETs are most prevalent, in ... Keywords: Gastroenteropancreatic neuroendocrine neoplasms; Global epidemiology; Incidence; Neuroendocrine carcinoma; ...
... adenocarcinoma intestinal type and non-intestinal type, undifferentiated carcinoma, neoplasms with neuroendocrine ... Neoplasms of the gastro-intestinal tract.. Polyps: hamartomatous polyps, polyps in Peutz-Jeghers syndrome, hyperplastic and ... Urothelial neoplasms: papilloma, papillary urothelial neoplasm of low malignant potential (PUNLMP), urothelial carcinoma in ... Classification, cystic neoplasms, IPMN (Intraductal papillary mucinous neoplasm), solid pseudopapillary tumor, ductal and ...
Intestinal Neoplasms / drug therapy * Lacrimal Duct Obstruction / chemically induced* * Male * Middle Aged ...
Malignant neoplasm of endocrine pancreas C26.0 Malignant neoplasm of intestinal tract, part unspecified ...
Categories: Intestinal Neoplasms Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
Skin Neoplasms. 1. 2018. 5479. 0.170. Why? Intestinal Neoplasms. 1. 2021. 319. 0.170. Why? ...
Intestinal Neoplasms. Orner GA, Dashwood W-M, Blum CA, G Díaz D, Li Q, Al-Fageeh M, Tebbutt N, Heath JK, Ernst M, Dashwood RH. ... Intestinal Mucosa. Orner GA, Dashwood W-M, Blum CA, G Díaz D, Li Q, Al-Fageeh M, Tebbutt N, Heath JK, Ernst M, Dashwood RH. ...
Intestinal Neoplasms. Orner GA, Dashwood W-M, Blum CA, G Díaz D, Li Q, Al-Fageeh M, Tebbutt N, Heath JK, Ernst M, Dashwood RH. ... Intestinal Mucosa. Orner GA, Dashwood W-M, Blum CA, G Díaz D, Li Q, Al-Fageeh M, Tebbutt N, Heath JK, Ernst M, Dashwood RH. ...
Intestinal obstruction: Neoplasm, incarcerated hernia, volvulus, adhesions. Genitourinary (GU) tract causes of unexpected death ... Neoplasms: Lung, breast, GI tract (especially the colon), pancreas, ovary/uterus, testis, melanoma, lymphoma ... Asphyxia: Mechanical airway obstruction (café coronary); laryngeal edema from infection (epiglottitis), anaphylaxis, neoplasm, ...
We present a case of primary intestinal NK/T cell lymphoma with diagnostic challenge, which eventually developed into multiple ... Eleven months follow-up was uneventful.Conclusion: Early diagnosis of primary intestinal NK/T cell lymphoma is frequently ... Conclusion: Early diagnosis of primary intestinal NK/T cell lymphoma is frequently difficult. Most patients were definitely ... During the hospitalization, the patient developed intestinal perforation and an emergency surgery was performed. The resected ...
ClinicalTrials.gov: Duodenal Neoplasms (National Institutes of Health) * ClinicalTrials.gov: Gastrointestinal Stromal Tumors ( ... Intestinal cancer is rare, but eating a high-fat diet or having Crohns disease, celiac disease, or a history of colonic polyps ... Imaging tests that create pictures of the small intestine and the area around it can help diagnose intestinal cancer and show ... Intestinal Cancer Also called: Duodenal cancer, Ileal cancer, Jejunal cancer, Small intestine cancer ...
Intestinal Diseases, Perioperative Period, Obesity, Neoplasms, Deglutition, Nutrition Assessment, Micronutrients, 52503 * Share ...
In animal studies, exposure to undegraded and degraded carrageenan is associated with intestinal ulcerations and neoplasms.48 ...
Rectal Neoplasms, Gastrointestinal Neoplasms, Intestinal Diseases I Fórum de Saúde Emocional do Distrito Federal. ...
ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial ... mainly in the treatment of neuroendocrine neoplasms by using 177Lu-labeled somatostatin analogs or in the treatment of advanced ... such as regulation of intestinal motility, secretion of the pancreas, and tone of smooth vascular muscles (42). ... neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172-185. ...
Extra-intestinal neoplasms can metastasize to the small bowel through hematogenous spread (breast, lung, and melanoma), direct ... Half of these patients undergo emergency surgery for intestinal obstruction as in this case. Abdominal pain and weight loss ... However, metastatic involvement of the intestine is more common than primary small intestinal neoplasia. ... Generally, nausea, vomiting, and intestinal obstruction are common presenting symptoms. ...
... intestinal obstruction, and use of cytotoxic agents or corticosteroids (8). In both of our patients, fever was noted and no ... Predisposing factors to Bacteroides species bacteremia include malignant neoplasms, recent gastrointestinal or obstetric- ...
... in the differential diagnosis with intestinal tract tumors this can be very helpful (the neoplasms of intestinal tract origin ... These neoplasms can be divided in two subtypes:. *. APTSs, Atypical proliferative serous tumors, behave in a benign way and ... They represent the 70% of BOTs, and 9-15% of all serous neoplasms [11,12] the mean age at presentation is 38 years old (range ... These neoplasms very rarely present with peritoneal implants or signs of microinvasion (defined as the presence of single or ...
in waters, which through their bone prick…we can contract these viruses] Gastro intestinal tract neoplasms, abdominal lymphomas ... So endogenous oestrogens surveillance of cell physiology, serves to protect the cell from neoplasms, [protects from specially ... neoplasms in any tissue e.g: leiomyoma-uterus, fibroadenoma breast, impaired secondary sexual dimorphism[normally shoulders ... followed by new cell formation is God ordained marvel physiology to protect every cell from neoplasms/cancer [eg: endogenous ...
Recommendations for treatment of NETs that secrete vasoactive intestinal peptide (VIPomas) include the following:. * Stabilize ... Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann ... ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum. Neuroendocrinology. 2016. 103 (2):125- ... ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial ...
Intestinal Mucosa/microbiology/pathology, Intestinal Neoplasms/microbiology/pathology, Male, Metagenome/genetics/physiology, ... Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome 2009 ... Host phenotypes were histologically defined as normal, esophagitis, or Barretts esophagus (intestinal metaplasia). Microbiomes ... BACKGROUND & AIMS: Gastroesophageal reflux causes inflammation and intestinal metaplasia and its downstream sequelum ...
The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Philos Trans R Soc Lond B Biol Sci. ... Intestinal-like metaplasia appears to be more differentiated, with lower levels of Notch signaling and less proliferation [30, ... Although presence of BE with intestinal mataplasia is linked to higher rates of EAC-development, in many cases EAC is diagnosed ... Since BE exhibits a metaplastic mosaic [27], with areas of gastric and intestinal metaplasia, we wanted to investigate whether ...
Ning Ding, Xin Zhang, Xue Di Zhang, Jun Jing, Shan Shan Liu, Yun Ping Mu, Li Li Peng, Yun Jing Yan, Geng Miao Xiao, Xin Yun Bi, Hao Chen, Fang Hong Li, Bing Yao, Allan Z Zhao ...
Sigmoid Neoplasms [C06.405.469.158.850.850]. *Intestinal Neoplasms [C06.405.469.491]. *Colorectal Neoplasms [C06.405.469.491. ... "Sigmoid Neoplasms" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Sigmoid Neoplasms" by people in UAMS Profiles by year, and ... Below are the most recent publications written about "Sigmoid Neoplasms" by people in Profiles over the past ten years. ...
The intestinal stem cell.. Barker, N., van de Wetering, M. L. & Clevers, H., 2008, In: Genes & Development. 22, 14, blz. 1856- ... The Intestinal Wnt/TCF Signature. Flier, L. G. V. D., Sabates-Bellver, J., Oving, I., Haegebarth, A., Palo, M. D., Anti, M., ... The intestinal crypt, a prototype stem cell compartment. Clevers, H., 2013, In: Cell. 154, 2, blz. 274-284. Onderzoeksoutput: ... The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent +4 cell markers. Munoz, J., Stange, D. E., ...
  • The normal small bowel contains gas and chyle, which is the sum of food and salivary, gastric, biliary, pancreatic, and intestinal secretions. (medscape.com)
  • The distribution of GEP NETs differs regionally as in North America small intestinal and rectal NETs are most prevalent, in Asia rectal and pancreatic NETs are most prevalent, and in Europe small intestinal and pancreatic NETs are most prevalent. (nih.gov)
  • A general surgeon performs a wide range of abdominal surgeries for many forms of intestinal and abdominal wall neoplasms, gallbladder disease, gastric and pancreatic disease. (findatopdoc.com)
  • Pancreatic neuroendocrine neoplasms (pNENs) are an increasingly common group of malignancies that arise within the endocrine tissue of the pancreas. (rarediseases.org)
  • A usually malignant pancreatic neuroendocrine tumor producing vasoactive intestinal peptide (VIP). (nih.gov)
  • Intestinal neoplasms can refer to: Small intestine cancer Colorectal cancer This disambiguation page lists articles associated with the title Intestinal neoplasms. (wikipedia.org)
  • 8 Primary colorectal lymphomas are less frequent, accounting for only 0.2% of all colonic neoplasms. (consultant360.com)
  • For these reasons iFOBT has better specificity and equal or better sensitivity than gFOBT for the detection of colorectal neoplasms ( 9 , 10 ). (cdc.gov)
  • Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms . (lookformedical.com)
  • A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. (nih.gov)
  • Of this uncommon group of highly malignant neoplasms, the leiomyosarcoma is the most common histiotype. (medscape.com)
  • Intestinal anastomosis is one of the most commonly performed surgical procedures, especially in the emergency setting, and is also commonly performed in the elective setting when resections are carried out for benign or malignant lesions of the gastrointestinal tract. (medscape.com)
  • The original procedure involved en bloc removal of a tumor together with the intestine , ex vivo resection and reconstruction of gastrointestinal tract by an intestinal autograft . (bvsalud.org)
  • Nonfunctioning neuroendocrine neoplasms can still cause symptoms relating to tumor size and location such as obstruction or internal bleeding. (rarediseases.org)
  • A leiomyoma is a relatively harmless and non-spreading tumor that arises from the smooth muscle of the stomach and intestinal tract. (petmd.com)
  • Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? (nih.gov)
  • Intestinal obstruction should be suspected in any child with persistent vomiting, abdominal distention, and abdominal pain. (medscape.com)
  • Intussusception is the most common cause of intestinal obstruction in infants and children aged 3 months to 6 years. (medscape.com)
  • 5 Patients with MCL affecting the GI tract may present with nonspecific signs and symptoms such as abdominal pain, diarrhea, obstruction, hematochezia, intestinal malabsorption, chylous ascites, and acute abdomen due to perforation. (consultant360.com)
  • When abdominal neoplasms originating from the pancreas or nearby organs locally involving the superior mesenteric artery (SMA), complete resection is still the only hope for cure . (bvsalud.org)
  • Abdominal CT revealed multi-segmental intestinal wall thickening. (frontiersin.org)
  • Abdominal & Intestinal surgeries for mesenteric/omental cysts, duplication cysts, irreducible intussusceptions & neoplasms. (klehospital.org)
  • Intestinal cancer is rare, but eating a high-fat diet or having Crohn's disease , celiac disease, or a history of colonic polyps can increase your risk. (medlineplus.gov)
  • Narita T, Ohnuma H, Yokoyama S. Peutz-Jeghers syndrome with osseous metaplasia of the intestinal polyps. (ac.ir)
  • Imaging tests that create pictures of the small intestine and the area around it can help diagnose intestinal cancer and show whether it has spread. (medlineplus.gov)
  • Intestinal anastomosis is a surgical procedure to establish communication between two formerly distant portions of the intestine. (medscape.com)
  • Today, I want to talk about the management of gastric intestinal metaplasia (GIM). (medscape.com)
  • There are two instruments used for histopathologic assessment that can portend greater risk for progression: the operative link on gastritis assessment (OLGA) and the operative link on gastric intestinal metaplasia assessment (OLGIM) staging systems. (medscape.com)
  • Since the pioneering use of 131 I in differentiated thyroid cancer in the 1940s, remarkable achievements in nuclear medicine endoradiotherapy have been demonstrated, mainly in the treatment of neuroendocrine neoplasms by using 177 Lu-labeled somatostatin analogs or in the treatment of advanced prostate cancer using prostate-specific membrane antigen-directed radionuclide therapy. (snmjournals.org)
  • The IL-17A/G-197A polymorphism was more closely correlated to intestinal-type cancer than diffuse-type cancer. (fujita-hu.ac.jp)
  • We concluded that G-197A polymorphism of IL-17A gene was significantly associated with the development of gastric cancer, especially intestinal-type cancer. (fujita-hu.ac.jp)
  • Results: LIMK2 expression was reduced in intestinal tumours of cancer-prone mice, as well as in human CRC cell lines and tumours. (elsevierpure.com)
  • With respect to intestinal cancer especially, but perhaps to the other diet-related cancers as well, the questions of dietary fiber, of micronutrients such as vitamins A and E, or of minerals such as selenium require consideration and further research. (cdc.gov)
  • These noncardia intestinal-type gastric cancers follow a stepwise progression known as the Correa cascade. (medscape.com)
  • Gastrointestinal reconstruction by intestinal auto-transplantation after radical resection of neoplasms involving superior mesenteric artery: a preliminary consideration]. (bvsalud.org)
  • Genetic analysis in Drosophila midgut and intestinal epithelial cells isolated from genetically modified mice revealed a conserved role for LIMK2 in constraining gastrointestinal stem cell proliferation. (elsevierpure.com)
  • This Clinical Policy Bulletin addresses treatment approaches for liver and other neoplasms. (aetna.com)
  • Percutaneous ethanol injection (PEI) for liver neoplasms when criteria above are not met. (aetna.com)
  • Undiagnosed or improperly managed obstructions can progress to intestinal ischemia, which in turn can progress to necrosis, perforation, and sepsis when left untreated. (medscape.com)
  • During the hospitalization, the patient developed intestinal perforation and an emergency surgery was performed. (frontiersin.org)
  • We present a case of primary intestinal NK/T cell lymphoma with diagnostic challenge, which eventually developed into multiple intestinal perforations. (frontiersin.org)
  • Early diagnosis of primary intestinal NK/T cell lymphoma is frequently difficult. (frontiersin.org)
  • and lymphoma, a solid neoplasm that originates in the lymphocytes -- a type of white blood cell in the bloodstream. (petmd.com)
  • [ 1 ] Intestinal leiomyosarcomas are mesenchymal tumors of smooth muscle origin. (medscape.com)
  • Pediatric small bowel obstructions have a variable etiology, with processes that can be divided into acute intestinal obstructions and chronic, partial intestinal obstructions. (medscape.com)
  • The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. (lookformedical.com)
  • Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. (lookformedical.com)
  • These conditions can be further subdivided into those that present in the immediate postnatal period (congenital intestinal obstructions) and those that occur later in childhood. (medscape.com)
  • The present case highlights the need for a better understanding of this entity so as to provide long-term survivals as these are possible in grade 1 and grade 2 neuroendocrine neoplasms including gastroenteropancreatic neuroendocrine neoplasms. (pancreasandliversurgeon.com)
  • Intestinal absorption, lymphatic drainage, and perfusion are compromised when intraluminal pressure exceeds capillary and venous pressure in the bowel wall. (medscape.com)
  • Although intestinal autotransplantation has expanded eligibility for resection of otherwise unresectable lesions involving the SMA, its operative complexity, high risks , and post-operative complications largely limit its clinical applications. (bvsalud.org)
  • However, bleeding from upper intestinal tract lesions, including erosions, ulcers, and hemorrhagic gastritis from Helicobacter pylori infection ( 5 ) or nonsteroidal anti-inflammatory medications ( 6 ) may cause gFOBT false-positive results, as can nonhuman heme from ingesting red meat or ingesting foods with peroxidase activity (eg, spinach). (cdc.gov)
  • Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. (lookformedical.com)
  • Because globin is degraded as it transits the upper intestinal tract, iFOBT is used to detect lower intestinal bleeding. (cdc.gov)
  • Sigmoid Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (uams.edu)
  • Ability of neoplasms to infiltrate and actively destroy surrounding tissue. (lookformedical.com)
  • Neoplasms that arise from endocrine tissue may also secrete hormones, resulting in excessive levels of these hormones in the body and potentially a wide variety of symptoms. (rarediseases.org)
  • To further refine this complex procedure , a modified method was developed in which a segmental bowel autograft is selected and harvested first during the initial stage of the operation, and radical resection of the neoplasm is carried out thereafter. (bvsalud.org)
  • Indications for intestinal anastomosis can be broadly divided into two categories: restoration of bowel continuity following resection of diseased bowel and bypass of unresectable diseased bowel. (medscape.com)
  • This procedure restores intestinal continuity after removal of a pathologic condition affecting the bowel. (medscape.com)